245 related articles for article (PubMed ID: 29025923)
1. Plasticity of Signaling by Spinal Estrogen Receptor α, κ-Opioid Receptor, and Metabotropic Glutamate Receptors over the Rat Reproductive Cycle Regulates Spinal Endomorphin 2 Antinociception: Relevance of Endogenous-Biased Agonism.
Liu NJ; Murugaiyan V; Storman EM; Schnell SA; Kumar A; Wessendorf MW; Gintzler AR
J Neurosci; 2017 Nov; 37(46):11181-11191. PubMed ID: 29025923
[TBL] [Abstract][Full Text] [Related]
2. Spinal endomorphin 2 antinociception and the mechanisms that produce it are both sex- and stage of estrus cycle-dependent in rats.
Liu NJ; Gintzler AR
J Pain; 2013 Nov; 14(11):1522-30. PubMed ID: 24084000
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic.
Kumar A; Liu NJ; Madia PA; Gintzler AR
J Pain; 2015 Nov; 16(11):1200-10. PubMed ID: 26342648
[TBL] [Abstract][Full Text] [Related]
4. Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal κ- and μ-opioid receptor heterodimerization and female-specific spinal morphine antinociception.
Liu NJ; Chakrabarti S; Schnell S; Wessendorf M; Gintzler AR
J Neurosci; 2011 Aug; 31(33):11836-45. PubMed ID: 21849544
[TBL] [Abstract][Full Text] [Related]
5. Estrogens Suppress Spinal Endomorphin 2 Release in Female Rats in Phase with the Estrous Cycle.
Kumar A; Storman EM; Liu NJ; Gintzler AR
Neuroendocrinology; 2015; 102(1-2):33-43. PubMed ID: 25925013
[TBL] [Abstract][Full Text] [Related]
6. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
7. Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.
Chakrabarti S; Liu NJ; Gintzler AR
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20115-9. PubMed ID: 21041644
[TBL] [Abstract][Full Text] [Related]
8. Sex-/ovarian steroid-dependent release of endomorphin 2 from spinal cord.
Gupta DS; von Gizycki H; Gintzler AR
J Pharmacol Exp Ther; 2007 May; 321(2):635-41. PubMed ID: 17308039
[TBL] [Abstract][Full Text] [Related]
9. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.
Lawson KP; Nag S; Thompson AD; Mokha SS
Pain; 2010 Dec; 151(3):806-815. PubMed ID: 20926192
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic.
Chakrabarti S; Liu NJ; Zadina JE; Sharma T; Gintzler AR
J Pharmacol Exp Ther; 2012 Jan; 340(1):56-63. PubMed ID: 21972236
[TBL] [Abstract][Full Text] [Related]
11. Kappa opioid receptors in rat spinal cord vary across the estrous cycle.
Chang PC; Aicher SA; Drake CT
Brain Res; 2000 Apr; 861(1):168-72. PubMed ID: 10751578
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of endomorphin-2: suppression of substance P release in the inflammatory pain model rat.
Wu XN; Zhang T; Qian NS; Guo XD; Yang HJ; Huang KB; Luo GQ; Xiang W; Deng WT; Dai GH; Peng KR; Pan SY
Neurochem Int; 2015 Mar; 82():1-9. PubMed ID: 25661513
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of spinal endomorphin-2 correlates with mechanical allodynia in a rat model of tibia cancer.
Chen L; Wang K; Yang T; Wang W; Mei XP; Zhu C; Wang W; Zhang FX; Li YQ
Neuroscience; 2015 Feb; 286():151-61. PubMed ID: 25457129
[TBL] [Abstract][Full Text] [Related]
14. Sex, pain, and opioids: interdependent influences of sex and pain modality on dynorphin-mediated antinociception in rats.
Liu NJ; Schnell S; Wessendorf MW; Gintzler AR
J Pharmacol Exp Ther; 2013 Feb; 344(2):522-30. PubMed ID: 23230215
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
17. Endogenous endomorphin-2 contributes to spinal ĸ-opioid antinociception.
Shimoyama M; Toyama S; Tagaito Y; Shimoyama N
Pharmacology; 2012; 89(3-4):145-8. PubMed ID: 22414674
[TBL] [Abstract][Full Text] [Related]
18. Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine.
Liu NJ; von Gizycki H; Gintzler AR
J Pharmacol Exp Ther; 2007 Aug; 322(2):654-60. PubMed ID: 17488879
[TBL] [Abstract][Full Text] [Related]
19. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
[TBL] [Abstract][Full Text] [Related]
20. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
